APO RESEARCH · REPORT
3-in-1 Oral CBCT
3-in-1 Oral CBCT is a medical imaging or procedural device supplied for the named examination or intervention.

Product & engineering
Understand the product.
The imaging or procedural modality, patient interface, connected instruments and product-specific validation define its use. Device appearance or a dimensional label does not establish an indication or clinical outcome.
The commercial boundary
The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.
Which modality and connected clinical interfaces define the device?
The imaging or procedural modality, patient interface, connected instruments and product-specific validation define its use. Device appearance or a dimensional label does not establish an indication or clinical outcome.
Selected research
Industry Growth & Trends
Global 3-in-1 Oral CBCT Industry Growth and Trends Forecast to 2032
Market perspective
The global 3-in-1 Oral CBCT market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for 3-in-1 Oral CBCT is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for 3-in-1 Oral CBCT is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 3-in-1 Oral CBCT is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 3-in-1 Oral CBCT include Instrumentarium, Vatech, Carestream Health, Planmeca, Hefei Meyer, Ray Co., Ltd, Guangzhou Huaduantech, FUSSEN and Shanghai Bondent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global 3-in-1 Oral CBCT market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The 3-in-1 Oral CBCT market size, estimates, and forecasts are presented in terms of sales volume (units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 3-in-1 Oral CBCT market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 3-in-1 Oral CBCT.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global 3-in-1 Oral CBCT market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
3-in-1 Oral CBCT Market by Company
Instrumentarium
Vatech
Carestream Health
Planmeca
Hefei Meyer
Ray Co., Ltd
Guangzhou Huaduantech
FUSSEN
Shanghai Bondent
Beijing Largev
Shenzhen Angell
Pointnix
NewTom
KaVo Dental
Genoray
DEXIS
3-in-1 Oral CBCT Segment by Type
Big FOV
Medium and Small FOV
3-in-1 Oral CBCT Segment by Application
Private Clinic
Hospital
3-in-1 Oral CBCT Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3-in-1 Oral CBCT market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 3-in-1 Oral CBCT and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3-in-1 Oral CBCT.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 3-in-1 Oral CBCT manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of 3-in-1 Oral CBCT in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Big FOV
- Medium and Small FOV
Applications
- Private Clinic
- Hospital
Companies covered
- Instrumentarium
- Vatech
- Carestream Health
- Planmeca
- Hefei Meyer
- Ray Co., Ltd
- Guangzhou Huaduantech
- FUSSEN
- Shanghai Bondent
- Beijing Largev
- Shenzhen Angell
- Pointnix
- NewTom
- KaVo Dental
- Genoray
- DEXIS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global 3-in-1 Oral CBCT Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global 3-in-1 Oral CBCT Sales Estimates and Forecasts (2021-2032)
- 1.3 3-in-1 Oral CBCT Market by Type
- 1.3.1 Big FOV
- 1.3.2 Medium and Small FOV
- 1.4 Global 3-in-1 Oral CBCT Market Size by Type
- 1.4.1 Global 3-in-1 Oral CBCT Market Size Overview by Type (2021-2032)
- 1.4.2 Global 3-in-1 Oral CBCT Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global 3-in-1 Oral CBCT Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America 3-in-1 Oral CBCT Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe 3-in-1 Oral CBCT Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific 3-in-1 Oral CBCT Sales Breakdown by Type (2021-2026)
- 1.5.4 South America 3-in-1 Oral CBCT Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa 3-in-1 Oral CBCT Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 3-in-1 Oral CBCT Industry Trends
- 2.2 3-in-1 Oral CBCT Industry Drivers
- 2.3 3-in-1 Oral CBCT Industry Opportunities and Challenges
- 2.4 3-in-1 Oral CBCT Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by 3-in-1 Oral CBCT Revenue (2021-2026)
- 3.2 Global Top Players by 3-in-1 Oral CBCT Sales (2021-2026)
- 3.3 Global Top Players by 3-in-1 Oral CBCT Price (2021-2026)
- 3.4 Global 3-in-1 Oral CBCT Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 3-in-1 Oral CBCT Major Company Production Sites & Headquarters
- 3.6 Global 3-in-1 Oral CBCT Company, Product Type & Application
- 3.7 Global 3-in-1 Oral CBCT Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 3-in-1 Oral CBCT Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 3-in-1 Oral CBCT Players Market Share by Revenue in 2025
- 3.8.3 2025 3-in-1 Oral CBCT Tier 1, Tier 2, and Tier 3
4 3-in-1 Oral CBCT Regional Status and Outlook
- 4.1 Global 3-in-1 Oral CBCT Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global 3-in-1 Oral CBCT Historic Market Size by Region
- 4.2.1 Global 3-in-1 Oral CBCT Sales in Volume by Region (2021-2026)
- 4.2.2 Global 3-in-1 Oral CBCT Sales in Value by Region (2021-2026)
- 4.2.3 Global 3-in-1 Oral CBCT Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global 3-in-1 Oral CBCT Forecasted Market Size by Region
- 4.3.1 Global 3-in-1 Oral CBCT Sales in Volume by Region (2027-2032)
- 4.3.2 Global 3-in-1 Oral CBCT Sales in Value by Region (2027-2032)
- 4.3.3 Global 3-in-1 Oral CBCT Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 3-in-1 Oral CBCT by Application
- 5.1 3-in-1 Oral CBCT Market by Application
- 5.1.1 Private Clinic
- 5.1.2 Hospital
- 5.2 Global 3-in-1 Oral CBCT Market Size by Application
- 5.2.1 Global 3-in-1 Oral CBCT Market Size Overview by Application (2021-2032)
- 5.2.2 Global 3-in-1 Oral CBCT Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global 3-in-1 Oral CBCT Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America 3-in-1 Oral CBCT Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe 3-in-1 Oral CBCT Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific 3-in-1 Oral CBCT Sales Breakdown by Application (2021-2026)
- 5.3.4 South America 3-in-1 Oral CBCT Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa 3-in-1 Oral CBCT Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Instrumentarium
- 6.1.1 Instrumentarium Company Information
- 6.1.2 Instrumentarium Business Overview
- 6.1.3 Instrumentarium 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Instrumentarium 3-in-1 Oral CBCT Product Portfolio
- 6.1.5 Instrumentarium Recent Developments
- 6.2 Vatech
- 6.2.1 Vatech Company Information
- 6.2.2 Vatech Business Overview
- 6.2.3 Vatech 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Vatech 3-in-1 Oral CBCT Product Portfolio
- 6.2.5 Vatech Recent Developments
- 6.3 Carestream Health
- 6.3.1 Carestream Health Company Information
- 6.3.2 Carestream Health Business Overview
- 6.3.3 Carestream Health 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Carestream Health 3-in-1 Oral CBCT Product Portfolio
- 6.3.5 Carestream Health Recent Developments
- 6.4 Planmeca
- 6.4.1 Planmeca Company Information
- 6.4.2 Planmeca Business Overview
- 6.4.3 Planmeca 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Planmeca 3-in-1 Oral CBCT Product Portfolio
- 6.4.5 Planmeca Recent Developments
- 6.5 Hefei Meyer
- 6.5.1 Hefei Meyer Company Information
- 6.5.2 Hefei Meyer Business Overview
- 6.5.3 Hefei Meyer 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Hefei Meyer 3-in-1 Oral CBCT Product Portfolio
- 6.5.5 Hefei Meyer Recent Developments
- 6.6 Ray Co., Ltd
- 6.6.1 Ray Co., Ltd Company Information
- 6.6.2 Ray Co., Ltd Business Overview
- 6.6.3 Ray Co., Ltd 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Ray Co., Ltd 3-in-1 Oral CBCT Product Portfolio
- 6.6.5 Ray Co., Ltd Recent Developments
- 6.7 Guangzhou Huaduantech
- 6.7.1 Guangzhou Huaduantech Company Information
- 6.7.2 Guangzhou Huaduantech Business Overview
- 6.7.3 Guangzhou Huaduantech 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Guangzhou Huaduantech 3-in-1 Oral CBCT Product Portfolio
- 6.7.5 Guangzhou Huaduantech Recent Developments
- 6.8 FUSSEN
- 6.8.1 FUSSEN Company Information
- 6.8.2 FUSSEN Business Overview
- 6.8.3 FUSSEN 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 FUSSEN 3-in-1 Oral CBCT Product Portfolio
- 6.8.5 FUSSEN Recent Developments
- 6.9 Shanghai Bondent
- 6.9.1 Shanghai Bondent Company Information
- 6.9.2 Shanghai Bondent Business Overview
- 6.9.3 Shanghai Bondent 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Shanghai Bondent 3-in-1 Oral CBCT Product Portfolio
- 6.9.5 Shanghai Bondent Recent Developments
- 6.10 Beijing Largev
- 6.10.1 Beijing Largev Company Information
- 6.10.2 Beijing Largev Business Overview
- 6.10.3 Beijing Largev 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Beijing Largev 3-in-1 Oral CBCT Product Portfolio
- 6.10.5 Beijing Largev Recent Developments
- 6.11 Shenzhen Angell
- 6.11.1 Shenzhen Angell Company Information
- 6.11.2 Shenzhen Angell Business Overview
- 6.11.3 Shenzhen Angell 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Shenzhen Angell 3-in-1 Oral CBCT Product Portfolio
- 6.11.5 Shenzhen Angell Recent Developments
- 6.12 Pointnix
- 6.12.1 Pointnix Company Information
- 6.12.2 Pointnix Business Overview
- 6.12.3 Pointnix 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Pointnix 3-in-1 Oral CBCT Product Portfolio
- 6.12.5 Pointnix Recent Developments
- 6.13 NewTom
- 6.13.1 NewTom Company Information
- 6.13.2 NewTom Business Overview
- 6.13.3 NewTom 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 NewTom 3-in-1 Oral CBCT Product Portfolio
- 6.13.5 NewTom Recent Developments
- 6.14 KaVo Dental
- 6.14.1 KaVo Dental Company Information
- 6.14.2 KaVo Dental Business Overview
- 6.14.3 KaVo Dental 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 KaVo Dental 3-in-1 Oral CBCT Product Portfolio
- 6.14.5 KaVo Dental Recent Developments
- 6.15 Genoray
- 6.15.1 Genoray Company Information
- 6.15.2 Genoray Business Overview
- 6.15.3 Genoray 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Genoray 3-in-1 Oral CBCT Product Portfolio
- 6.15.5 Genoray Recent Developments
- 6.16 DEXIS
- 6.16.1 DEXIS Company Information
- 6.16.2 DEXIS Business Overview
- 6.16.3 DEXIS 3-in-1 Oral CBCT Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 DEXIS 3-in-1 Oral CBCT Product Portfolio
- 6.16.5 DEXIS Recent Developments
7 North America by Country
- 7.1 North America 3-in-1 Oral CBCT Sales by Country
- 7.1.1 North America 3-in-1 Oral CBCT Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America 3-in-1 Oral CBCT Sales by Country (2021-2026)
- 7.1.3 North America 3-in-1 Oral CBCT Sales Forecast by Country (2027-2032)
- 7.2 North America 3-in-1 Oral CBCT Market Size by Country
- 7.2.1 North America 3-in-1 Oral CBCT Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America 3-in-1 Oral CBCT Market Size by Country (2021-2026)
- 7.2.3 North America 3-in-1 Oral CBCT Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe 3-in-1 Oral CBCT Sales by Country
- 8.1.1 Europe 3-in-1 Oral CBCT Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe 3-in-1 Oral CBCT Sales by Country (2021-2026)
- 8.1.3 Europe 3-in-1 Oral CBCT Sales Forecast by Country (2027-2032)
- 8.2 Europe 3-in-1 Oral CBCT Market Size by Country
- 8.2.1 Europe 3-in-1 Oral CBCT Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe 3-in-1 Oral CBCT Market Size by Country (2021-2026)
- 8.2.3 Europe 3-in-1 Oral CBCT Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific 3-in-1 Oral CBCT Sales by Country
- 9.1.1 Asia-Pacific 3-in-1 Oral CBCT Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific 3-in-1 Oral CBCT Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific 3-in-1 Oral CBCT Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific 3-in-1 Oral CBCT Market Size by Country
- 9.2.1 Asia-Pacific 3-in-1 Oral CBCT Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific 3-in-1 Oral CBCT Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific 3-in-1 Oral CBCT Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America 3-in-1 Oral CBCT Sales by Country
- 10.1.1 South America 3-in-1 Oral CBCT Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America 3-in-1 Oral CBCT Sales by Country (2021-2026)
- 10.1.3 South America 3-in-1 Oral CBCT Sales Forecast by Country (2027-2032)
- 10.2 South America 3-in-1 Oral CBCT Market Size by Country
- 10.2.1 South America 3-in-1 Oral CBCT Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America 3-in-1 Oral CBCT Market Size by Country (2021-2026)
- 10.2.3 South America 3-in-1 Oral CBCT Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa 3-in-1 Oral CBCT Sales by Country
- 11.1.1 Middle East and Africa 3-in-1 Oral CBCT Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa 3-in-1 Oral CBCT Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa 3-in-1 Oral CBCT Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa 3-in-1 Oral CBCT Market Size by Country
- 11.2.1 Middle East and Africa 3-in-1 Oral CBCT Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa 3-in-1 Oral CBCT Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa 3-in-1 Oral CBCT Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 3-in-1 Oral CBCT Value Chain Analysis
- 12.1.1 3-in-1 Oral CBCT Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 3-in-1 Oral CBCT Production Mode & Process
- 12.2 3-in-1 Oral CBCT Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 3-in-1 Oral CBCT Distributors
- 12.2.3 3-in-1 Oral CBCT Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst